Precision Treatment of Unresectable HCC Guided by Multi-omics Deep Learning Models
NCT06463444
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
HCC
Precision Therapy
Interventions
DRUG:
HAIC + Tislelizumab +lenvatinib
Sponsor
Chen Xiaoping